Trastuzumab Not Yet Recruiting Phase 2 Trials for Cancer, Breast / Estrogen Receptor Positive Tumor / Her2-Positive Breast Cancer Treatment

Not Yet RecruitingTreatment2 IdentifierTitleDrugs
NCT03820141Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
NCT03765983GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
NCT03747120Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab
NCT0336767612 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)